PDB Short entry for 3EKO HEADER CHAPERONE 19-SEP-08 3EKO TITLE DIHYDROXYLPHENYL AMIDES AS INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN: UNP RESIDUES 9-225; COMPND 5 SYNONYM: HSP 86, RENAL CARCINOMA ANTIGEN NY-REN-38; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 GENE: HSP90AA1, HSP90A, HSPC1, HSPCA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI KEYWDS HSP90 INHIBITORS, ALTERNATIVE SPLICING, ATP-BINDING, CHAPERONE, KEYWDS 2 CYTOPLASM, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, STRESS RESPONSE EXPDTA X-RAY DIFFRACTION AUTHOR K.S.GAJIWALA REVDAT 3 21-FEB-24 3EKO 1 REMARK SEQADV REVDAT 2 24-FEB-09 3EKO 1 VERSN REVDAT 1 25-NOV-08 3EKO 0 JRNL AUTH P.P.KUNG,L.FUNK,J.MENG,M.COLLINS,J.Z.ZHOU,M.C.JOHNSON, JRNL AUTH 2 A.EKKER,J.WANG,P.MEHTA,M.J.YIN,C.RODGERS,J.F.DAVIES, JRNL AUTH 3 E.BAYMAN,T.SMEAL,K.A.MAEGLEY,M.R.GEHRING JRNL TITL DIHYDROXYLPHENYL AMIDES AS INHIBITORS OF THE HSP90 MOLECULAR JRNL TITL 2 CHAPERONE. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 6273 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18929486 JRNL DOI 10.1016/J.BMCL.2008.09.081 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 334752.450 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 80044 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 5691 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2000 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2000 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 5785 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0030 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 81653 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 18111 REMARK 3 BIN R VALUE (WORKING SET) : 0.1900 REMARK 3 BIN FREE R VALUE : 0.2230 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 949 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.007 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3426 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 319 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.11000 REMARK 3 B22 (A**2) : -1.32000 REMARK 3 B33 (A**2) : 0.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.16 REMARK 3 ESD FROM SIGMAA (A) : -0.0 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.08 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.590 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.140 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.780 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.140 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.150 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 46.26 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PAR REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PAR REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIG.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : LIG.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3EKO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-SEP-08. REMARK 100 THE DEPOSITION ID IS D_1000049442. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-AUG-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 117734 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.410 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : 0.05900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 34 % ETHYLENE GLYCOL, 0.1 M PHOSHPATE REMARK 280 -CITRATE PH 4.4, 5 MM TCEP, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.77850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.08850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.61000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.08850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.77850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.61000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE TWO ISOLATED N-TERMINAL DOMAINS OF REMARK 300 HSP90 ARE MOST LIKELY MONOMERS IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 45.55700 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -39.61000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 59.08850 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 8 REMARK 465 ASP A 9 REMARK 465 GLU A 227 REMARK 465 HIS A 228 REMARK 465 HIS A 229 REMARK 465 HIS A 230 REMARK 465 HIS A 231 REMARK 465 HIS A 232 REMARK 465 HIS A 233 REMARK 465 MET B 8 REMARK 465 SER B 113 REMARK 465 GLU B 227 REMARK 465 HIS B 228 REMARK 465 HIS B 229 REMARK 465 HIS B 230 REMARK 465 HIS B 231 REMARK 465 HIS B 232 REMARK 465 HIS B 233 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 166 -150.11 66.54 REMARK 500 ARG A 182 142.57 -174.15 REMARK 500 ASP B 66 87.77 -156.09 REMARK 500 ALA B 166 -146.03 66.24 REMARK 500 ARG B 182 143.15 -171.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PYU A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PYU B 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3EKR RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR DBREF 3EKO A 9 225 UNP P07900 HS90A_HUMAN 9 225 DBREF 3EKO B 9 225 UNP P07900 HS90A_HUMAN 9 225 SEQADV 3EKO MET A 8 UNP P07900 EXPRESSION TAG SEQADV 3EKO LEU A 226 UNP P07900 EXPRESSION TAG SEQADV 3EKO GLU A 227 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS A 228 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS A 229 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS A 230 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS A 231 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS A 232 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS A 233 UNP P07900 EXPRESSION TAG SEQADV 3EKO MET B 8 UNP P07900 EXPRESSION TAG SEQADV 3EKO LEU B 226 UNP P07900 EXPRESSION TAG SEQADV 3EKO GLU B 227 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS B 228 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS B 229 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS B 230 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS B 231 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS B 232 UNP P07900 EXPRESSION TAG SEQADV 3EKO HIS B 233 UNP P07900 EXPRESSION TAG SEQRES 1 A 226 MET ASP GLN PRO MET GLU GLU GLU GLU VAL GLU THR PHE SEQRES 2 A 226 ALA PHE GLN ALA GLU ILE ALA GLN LEU MET SER LEU ILE SEQRES 3 A 226 ILE ASN THR PHE TYR SER ASN LYS GLU ILE PHE LEU ARG SEQRES 4 A 226 GLU LEU ILE SER ASN SER SER ASP ALA LEU ASP LYS ILE SEQRES 5 A 226 ARG TYR GLU SER LEU THR ASP PRO SER LYS LEU ASP SER SEQRES 6 A 226 GLY LYS GLU LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN SEQRES 7 A 226 ASP ARG THR LEU THR ILE VAL ASP THR GLY ILE GLY MET SEQRES 8 A 226 THR LYS ALA ASP LEU ILE ASN ASN LEU GLY THR ILE ALA SEQRES 9 A 226 LYS SER GLY THR LYS ALA PHE MET GLU ALA LEU GLN ALA SEQRES 10 A 226 GLY ALA ASP ILE SER MET ILE GLY GLN PHE GLY VAL GLY SEQRES 11 A 226 PHE TYR SER ALA TYR LEU VAL ALA GLU LYS VAL THR VAL SEQRES 12 A 226 ILE THR LYS HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SEQRES 13 A 226 SER SER ALA GLY GLY SER PHE THR VAL ARG THR ASP THR SEQRES 14 A 226 GLY GLU PRO MET GLY ARG GLY THR LYS VAL ILE LEU HIS SEQRES 15 A 226 LEU LYS GLU ASP GLN THR GLU TYR LEU GLU GLU ARG ARG SEQRES 16 A 226 ILE LYS GLU ILE VAL LYS LYS HIS SER GLN PHE ILE GLY SEQRES 17 A 226 TYR PRO ILE THR LEU PHE VAL GLU LYS GLU LEU GLU HIS SEQRES 18 A 226 HIS HIS HIS HIS HIS SEQRES 1 B 226 MET ASP GLN PRO MET GLU GLU GLU GLU VAL GLU THR PHE SEQRES 2 B 226 ALA PHE GLN ALA GLU ILE ALA GLN LEU MET SER LEU ILE SEQRES 3 B 226 ILE ASN THR PHE TYR SER ASN LYS GLU ILE PHE LEU ARG SEQRES 4 B 226 GLU LEU ILE SER ASN SER SER ASP ALA LEU ASP LYS ILE SEQRES 5 B 226 ARG TYR GLU SER LEU THR ASP PRO SER LYS LEU ASP SER SEQRES 6 B 226 GLY LYS GLU LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN SEQRES 7 B 226 ASP ARG THR LEU THR ILE VAL ASP THR GLY ILE GLY MET SEQRES 8 B 226 THR LYS ALA ASP LEU ILE ASN ASN LEU GLY THR ILE ALA SEQRES 9 B 226 LYS SER GLY THR LYS ALA PHE MET GLU ALA LEU GLN ALA SEQRES 10 B 226 GLY ALA ASP ILE SER MET ILE GLY GLN PHE GLY VAL GLY SEQRES 11 B 226 PHE TYR SER ALA TYR LEU VAL ALA GLU LYS VAL THR VAL SEQRES 12 B 226 ILE THR LYS HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SEQRES 13 B 226 SER SER ALA GLY GLY SER PHE THR VAL ARG THR ASP THR SEQRES 14 B 226 GLY GLU PRO MET GLY ARG GLY THR LYS VAL ILE LEU HIS SEQRES 15 B 226 LEU LYS GLU ASP GLN THR GLU TYR LEU GLU GLU ARG ARG SEQRES 16 B 226 ILE LYS GLU ILE VAL LYS LYS HIS SER GLN PHE ILE GLY SEQRES 17 B 226 TYR PRO ILE THR LEU PHE VAL GLU LYS GLU LEU GLU HIS SEQRES 18 B 226 HIS HIS HIS HIS HIS HET PYU A 901 16 HET PO4 B 902 5 HET PYU B 901 16 HETNAM PYU 2-(1H-PYRROL-1-YLCARBONYL)BENZENE-1,3,5-TRIOL HETNAM PO4 PHOSPHATE ION FORMUL 3 PYU 2(C11 H9 N O4) FORMUL 4 PO4 O4 P 3- FORMUL 6 HOH *319(H2 O) HELIX 1 1 GLN A 23 THR A 36 1 14 HELIX 2 2 GLU A 42 ASP A 66 1 25 HELIX 3 3 PRO A 67 ASP A 71 5 5 HELIX 4 4 THR A 99 LEU A 107 1 9 HELIX 5 5 LYS A 112 ALA A 124 1 13 HELIX 6 6 ASP A 127 GLY A 135 5 9 HELIX 7 7 VAL A 136 LEU A 143 5 8 HELIX 8 8 GLU A 192 LEU A 198 5 7 HELIX 9 9 GLU A 199 SER A 211 1 13 HELIX 10 10 GLN B 23 THR B 36 1 14 HELIX 11 11 GLU B 42 ASP B 66 1 25 HELIX 12 12 PRO B 67 ASP B 71 5 5 HELIX 13 13 THR B 99 LEU B 107 1 9 HELIX 14 14 GLY B 114 ALA B 124 1 11 HELIX 15 15 MET B 130 GLY B 135 5 6 HELIX 16 16 VAL B 136 LEU B 143 5 8 HELIX 17 17 GLU B 192 LEU B 198 5 7 HELIX 18 18 GLU B 199 SER B 211 1 13 SHEET 1 A 8 VAL A 17 ALA A 21 0 SHEET 2 A 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 A 8 GLN A 159 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 A 8 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 A 8 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149 SHEET 6 A 8 THR A 88 ASP A 93 -1 N LEU A 89 O LEU A 188 SHEET 7 A 8 ILE A 78 ASN A 83 -1 N ASN A 79 O VAL A 92 SHEET 8 A 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 SHEET 1 B 8 VAL B 17 ALA B 21 0 SHEET 2 B 8 SER B 169 THR B 174 -1 O PHE B 170 N PHE B 20 SHEET 3 B 8 GLN B 159 SER B 164 -1 N ALA B 161 O ARG B 173 SHEET 4 B 8 ALA B 145 LYS B 153 -1 N VAL B 150 O TRP B 162 SHEET 5 B 8 GLY B 183 LEU B 190 -1 O ILE B 187 N THR B 149 SHEET 6 B 8 THR B 88 ASP B 93 -1 N ILE B 91 O VAL B 186 SHEET 7 B 8 ILE B 78 ASN B 83 -1 N ASN B 79 O VAL B 92 SHEET 8 B 8 ILE B 218 LEU B 220 1 O THR B 219 N LEU B 80 SITE 1 AC1 11 ASN A 51 ALA A 55 LYS A 58 ASP A 93 SITE 2 AC1 11 ILE A 96 GLY A 97 MET A 98 THR A 184 SITE 3 AC1 11 HOH A 902 HOH A 904 HOH A 925 SITE 1 AC2 8 ARG A 201 GLU B 62 LYS B 69 HIS B 154 SITE 2 AC2 8 HOH B1004 HOH B1011 HOH B1047 HOH B1053 SITE 1 AC3 13 LEU B 48 ASN B 51 ALA B 55 LYS B 58 SITE 2 AC3 13 ASP B 93 ILE B 96 GLY B 97 MET B 98 SITE 3 AC3 13 THR B 184 VAL B 186 HOH B 996 HOH B 998 SITE 4 AC3 13 HOH B1029 CRYST1 45.557 79.220 118.177 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021951 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012623 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008462 0.00000